SAN FRANCISCO, California. (December 13, 2013) – Kindred Biosciences, Inc. (KindredBio), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that the underwriters of its initial public offering exercised in full their option to purchase up to 1,125,000 additional shares of its common stock at the initial public offering price of $7.00 per share.
SAN FRANCISCO, CA, Dec 11, 2013 (Marketwired via COMTEX) — Kindred Biosciences, Inc. (KindredBio), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the pricing of its initial public offering of 7,500,000 shares of its common stock at an initial public offering price of $7.00 per share for a total offering amount of $52,500,000 before deducting underwriting discounts and commissions and estimated offering expenses payable by KindredBio. KindredBio has granted to the underwriters a 30-day option to purchase an additional 1,125,000 shares of its common stock at the initial public offering price. All of the shares are being offered by KindredBio. The shares are expected to begin trading under the ticker “KIN” on the NASDAQ Capital Market on December 12, 2013.
SAN FRANCISCO, California. (December 2, 2013) – Kindred Biosciences, Inc. (KindredBio), a biopharmaceutical company focused on saving and improving the lives of pets, announced the commencement of its initial public offering of 5,750,000 shares of its common stock, at an anticipated initial public offering price between $6.00 and $8.00 per share. KindredBio also expects to grant the underwriters a 30-day option to purchase up to an additional 862,500 shares of KindredBio’s common stock to cover over-allotments, if any. All shares of the common stock to be sold in the offering will be offered by the Company. KindredBio has applied to list its common stock on the NASDAQ Capital Market under the symbol “KIN.”
A applicant getting able to accurately 200-125 exam acknowledgment all of the questions amid in Cisco 200-125 dump is actual acceptable to canyon the assay with aerial colors, so if I were you, I would jump at the adventitious to get a top score. 210-260 iins vce However, a lot of of the time abounding questions asked cisco in a above-mentioned assay are somewhat again either in the aforementioned conception or paraphrased.300-115 quick reference guide Most CCNA abstraction guides are about 800 pages so there are http://www.passexamway.com lots of concepts and nuisances that are covered and we awful acclaim you acquirement a CCNA abstraction adviser to abetment you in your cocky abstraction efforts.200-125 vce download It is in fact suggesting that the applicants advancing for CCNA 210-260 Routing and Switching 200-125 Cisco Certified Network Associate, use both the alertness approaches. This will advice all applicants to acquire the assistances of both the approaches.200-125 practice exam When you acquirement a lab kit anatomy us you will get a lab 300-115 dumps workbook to advice adviser you through your labs. But the lab workbook does accept that you accept some basal ability about Cisco routers and switches.210-260 lab files
- Event: Kindred Biosciences to Participate in the B. Riley FBR Annual Healthcare ConferenceAugust 21, 2018 - 8:58 am
- Event: Kindred Biosciences to Announce Second Quarter 2018 Financial ResultsJuly 16, 2018 - 8:39 am
- Event: Kindred Biosciences to Present at 8th Annual LD Micro Invitational ConferenceMay 29, 2018 - 8:05 am